Scholars Central

Research articlePublished 2013

Etanercept Patient Assistance Program: Another Data Source for Epidemiological Studies?

Authors: Brian C Chan, Soo Jin Seung, David McLean, Mary Bell, Neil H Shear, Nicole Mittmann

Advances in Pharmacoepidemiology and Drug Safety

Volume 2 · Issue 2 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Patient assistance programs (PAP) have been established for biologic disease modifying therapies such as etanercept to improve patient knowledge and compliance and provide a means for follow-up. The information collected through these programs is a potential data source to determine patient characteristics, patient outcomes, treatment adherence and reimbursement practices of individuals prescribed biologic disease modifying therapies. Objective: To describe the population enrolled in the Enliven® Services Patient Assistance Program and to determine one-year retention rates. Methods: A retrospective review of a Canadian cohort of patients enrolled in an etanercept PAP diagnosed with rheumatoid arthritis (RA) was conducted. Demographic and utilization information was collected for all subjects enrolled in the period between 2000 and 2007. One-year retention rates were also calculated from the data collected. Descriptive statistics were used to characterize the data. Results: 14,335 subjects prescribed etanercept were enrolled in Enliven®. Average age at time of enrollment was 53 years. Three-quarters of subjects were female and four-fifths were English speaking. The largest percentage Conclusion: The analysis provides a snapshot of individuals administered etanercept therapy over a 7-year timeframe. PAPs are a valuable source of data for research on biological therapies in addition to the support provided to the patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Advances in Pharmacoepidemiology and Drug Safety.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAdvances in Pharmacoepidemiology and Drug Safety
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Brian C Chan”
  • BylineArticles whose byline prints “Soo Jin Seung”
  • BylineArticles whose byline prints “David McLean”
  • BylineArticles whose byline prints “Mary Bell”
  • BylineArticles whose byline prints “Neil H Shear”
  • BylineArticles whose byline prints “Nicole Mittmann”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels